Product Introduction

SORFA serum is carefully selected from three blood sources: South America, North America, and Australia. It is filtered and packaged domestically. In addition to the regular 500ml and 100ml, we have specially launched a 50ml small specification that does not require packaging for scientific research users. This can save valuable time for scientific research users, as well as avoid contamination caused by packaging operations and the increase in sedimentation caused by secondary freezing and thawing. Widely used in research institutes, stable quality and batch sizes up to 3000L can also meet the high requirements of pharmaceutical companies.

Product Features

Low endotoxin content, ≤ 5EU/ml, beneficial for cell growth

Strict quality control with minimal inter batch variability

The maximum single batch production capacity is up to 3000L, fully meeting the user's requirements for batch production. It is a global serum producerOne of the largest factories in terms of production scale

Comprehensive quality inspection of finished products: each batch undergoes physical testing, biological testing, microbiological testing, and virus testingTesting, Cell Testing

Multiple virus tests: bovine parainfluenza virus (PI3), bovine adenovirus (BAV-3), bovine parvovirus (BPV), bovine diarrhea virus (BVDV), reovirus (REO-3), rabies virus (Rab), and bovine foot-and-mouth disease virus (FMDV) all tested negative (not detected)

Verified through over 200 cell cultures, suitable for the cultivation of various types of cells